This improvement of hepatic steatosis in IL-6RαT-KO animals was also paralleled by reduced signs of liver damage, as evidenced by lower serum levels of aspartate aminotransferase and alanine transaminase (Supplementary Table 2). This evidence concerns the gene GPT and Hepatic steatosis.